To evaluate, the over-time effects of xylometazoline hydrochloride 0.1% on additional measures of QoL factors among individuals experiencing nasal congestion associated with the common cold, following up to 7 days of treatment	Snoring (Q1), alertness (slow in responses) (Q2), feeling self-conscious about how you sound (Q3), feeling self-conscious around people (Q4), smell (Q5) and taste (Q6), energy (Q7), and motivation (Q8)